학술논문
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children
Document Type
Article
Author
Turkova, A.; White, E.; Ali, S.; Sarfati, T.; Wynne, B.; Shakeshaft, C.; Ford, D.; Gibb, D.M.; Klein, N.; Bernays, S.; Welch, S.B.; Mujuru, H.A.; Bwakura-Dangarembizi, M.; Musoro, G.; Kekitiinwa, A.R.; Amuge, P.; Bbuye, D.; Lugemwa, A.; Makumbi, S.; Atwine, L.; Kityo, C.M.; Kaudha, E.; Musiime, V.; Musoke, P.; Barlow-Mosha, L.; Ahimbisibwe, G.M.; Violari, A.; Variava, E.; Ramsagar, N.; Liberty, A.; Cotton, M.F.; Archary, M.; Behuhuma, O.; Cressey, T.R.; Chalermpantmetagul, S.; Puthanakit, T.; Ngampiyaskul, C.; Kobbe, R.; Colbers, A.; Saïdi, Y.; Coelho, A.; Compagnucci, A.; Grossele, T.; Giaquinto, C.; Rojo, P.
Source
In: New England Journal of Medicine . (New England Journal of Medicine, 30 December 2021, 385(27):2531-2543)
Subject
Language
English
ISSN
15334406
00284793
00284793